China Resources Boya Bio pharmaceutical Group Co Ltd SZSE:300294:
CR BOYA BIO-PHARMACEUTICAL QTRLY UNAUDITED REVENUE RMB 321.1 MILLION, NET PROFIT RMB 30.0 MILLION
China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million
Earlier from China Resources Boya Bio-pharmaceutical Group Co., Ltd. Class A
- China Resources Boya Bio-pharmaceutical Group: Revenue up, profit down sharply on impairments and margin pressure; high dividend payout maintained
- China Resources Pharmaceutical Logs FY Revenue RMB2.06 Bln For CR Boya Bio-Pharmaceutical
- China Resources Pharmaceutical: Hui Ren Resigns As President Due To Job Change
- China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million